We are a preclinical company developing cell-type-specific immune checkpoint activators to prevent multi-organ failure in autoimmune diseases.
We engineer next generation biologics that rebalance the immune response in acute and chronic inflammation.
The immune system is the all-powerful protector of the human body against bacteria, viruses and cancer. It has the potential to destroy everything that does not belong.